CHC LABS INC.
|
CARCINOEMBRYONIC ANTIGEN (CEA) (82378) |
|
|
150.0-150.9 |
Malignant neoplasm of cervical esophagus |
|
151.0-151.9 |
Malignant neoplasm of cardia |
|
152.0-154.8 |
Malignant neoplasm of duodenum |
|
157.0-157.9 |
Malignant neoplasm of head of pancreas |
|
159.0 |
Malignant neoplasm of intestinal tract part unspecified |
|
162.0-162.9 |
Malignant neoplasm of trachea |
|
174.0-174.9 |
Malignant neoplasm of nipple and areola of female breast |
|
175.0-175.9 |
Malignant neoplasm of nipple and areola of male breast |
|
183.0 |
Malignant neoplasm of ovary |
|
197.0 |
Secondary malignant neoplasm of lung |
|
197.4 |
Secondary malignant neoplasm of small intestine, including duodenum |
|
197.5 |
Secondary malignant neoplasm of large intestine and rectum |
|
230.3 |
Carcinoma in situ of colon |
|
230.4 |
Carcinoma in situ of rectum |
|
230.7 |
Carcinoma in situ of other and unspecified parts of intestine |
|
230.9 |
Carcinoma in situ of other and unspecified digestive organs |
|
235.2 |
Neoplasm of uncertain behavior of stomach, intestines, and rectum |
|
790.99 |
Other abnormal findings on examination of blood |
|
V10.00 |
Personal history of malignant neoplasm of unspecified site in gastrointestinal tract |
|
V10.05 |
Personal history of malignant neoplasm of large intestine |
|
V10.06 |
Personal history of malignant neoplasm, rectum, rectosigmoid junction, and anus |
|
V10.11 |
Personal history of malignant neoplasm of bronchus and lung |
|
V10.3 |
Personal history of malignant neoplasm of breast |
|
V10.43 |
Personal history of malignant neoplasm of ovary |
|
V67.2 |
Follow-up examination following chemotherapy |
11 This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|